239 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

2359

WuXi AppTec
CN¥36.35-2.0%-56.1%CN¥130.0bCN¥59.11PE14xE9.7%2.1%

2359

WuXi AppTec
CN¥36.35-2.0%-56.1%CN¥130.0bCN¥59.11PE14xE9.7%2.1%

2359

WuXi AppTec
CN¥36.35-2.0%-56.1%CN¥130.0bCN¥59.11PE14xE9.7%2.1%

6160

BeiGene
US$90.05-5.3%-33.0%US$15.7bUS$161.24PS6.4xE56.6%n/a

6160

BeiGene
US$90.05-5.3%-33.0%US$15.7bUS$161.24PS6.4xE56.6%n/a

6160

BeiGene
US$90.05-5.3%-33.0%US$15.7bUS$161.24PS6.4xE56.6%n/a

3692

Hansoh Pharmaceutical Group
HK$15.42-0.4%8.4%HK$91.3bHK$18.90PE25.7xE8.7%1.8%

3692

Hansoh Pharmaceutical Group
HK$15.42-0.4%8.4%HK$91.3bHK$18.90PE25.7xE8.7%1.8%

3692

Hansoh Pharmaceutical Group
HK$15.42-0.4%8.4%HK$91.3bHK$18.90PE25.7xE8.7%1.8%

1093

CSPC Pharmaceutical Group
HK$6.150%-20.2%HK$72.9bHK$9.35PE11.5xE4.5%4.5%

1093

CSPC Pharmaceutical Group
HK$6.150%-20.2%HK$72.9bHK$9.35PE11.5xE4.5%4.5%

1093

CSPC Pharmaceutical Group
HK$6.150%-20.2%HK$72.9bHK$9.35PE11.5xE4.5%4.5%

1801

Innovent Biologics
HK$36.55-3.1%-4.7%HK$59.3bHK$55.73PS8.8xE50.8%n/a

1801

Innovent Biologics
HK$36.55-3.1%-4.7%HK$59.3bHK$55.73PS8.8xE50.8%n/a

1801

Innovent Biologics
HK$36.55-3.1%-4.7%HK$59.3bHK$55.73PS8.8xE50.8%n/a

2196

Shanghai Fosun Pharmaceutical (Group)
CN¥12.10-5.5%-48.3%CN¥54.6bCN¥16.02PE25.6xE23.6%1.2%

2196

Shanghai Fosun Pharmaceutical (Group)
CN¥12.10-5.5%-48.3%CN¥54.6bCN¥16.02PE25.6xE23.6%1.2%

2196

Shanghai Fosun Pharmaceutical (Group)
CN¥12.10-5.5%-48.3%CN¥54.6bCN¥16.02PE25.6xE23.6%1.2%

2269

WuXi Biologics (Cayman)
HK$14.08-1.5%-70.3%HK$58.7bHK$30.81PE15.9xE14.3%n/a

2269

WuXi Biologics (Cayman)
HK$14.08-1.5%-70.3%HK$58.7bHK$30.81PE15.9xE14.3%n/a

2269

WuXi Biologics (Cayman)
HK$14.08-1.5%-70.3%HK$58.7bHK$30.81PE15.9xE14.3%n/a

1177

Sino Biopharmaceutical
HK$2.83-6.3%-31.8%HK$51.9bHK$4.67PE26xE15.1%1.8%

1177

Sino Biopharmaceutical
HK$2.83-6.3%-31.8%HK$51.9bHK$4.67PE26xE15.1%1.8%

1177

Sino Biopharmaceutical
HK$2.83-6.3%-31.8%HK$51.9bHK$4.67PE26xE15.1%1.8%
Page 1 of 10
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.